AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

By: AbCellera Biologics Inc. via Business Wire

October 07, 2025 at 16:05 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

Truist Securities BioPharma Symposium, November 6, 2025
Stifel Healthcare Conference, November 11-13, 2025
Jefferies Global Healthcare Conference, November 18-20, 2025
Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/

Contacts

Inquiries

Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005

Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	260.82	-0.44 (-0.17%)
AAPL	312.20	+5.89 (1.92%)
AMD	510.02	-0.11 (-0.02%)
BAC	52.52	+1.01 (1.96%)
GOOG	366.43	-6.15 (-1.65%)
META	607.73	+7.26 (1.21%)
MSFT	443.25	-17.27 (-3.75%)
NVDA	226.50	+2.14 (0.95%)
ORCL	240.63	-7.52 (-3.03%)
TSLA	421.08	+5.20 (1.25%)

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Contacts

More News

Recent Quotes